Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics

Medtronic plc. Ordinary Shares (MDT)

Today's Latest Price: $111.84 USD

2.61 (2.39%)

Updated Oct 22 4:00pm

Add MDT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MDT Stock Summary

  • MDT has a higher market value than 98.89% of US stocks; more precisely, its current market capitalization is $146,828,632,959.
  • MDT's went public 34.83 years ago, making it older than 92.9% of listed US stocks we're tracking.
  • In terms of volatility of its share price, MDT is more volatile than only 7.39% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Medtronic plc are DHR, TMUS, UNP, NVO, and SNY.
  • Visit MDT's SEC page to see the company's official filings. To visit the company's web site, go to

MDT Stock Price Chart Interactive Chart >

Price chart for MDT

MDT Price/Volume Stats

Current price $111.84 52-week high $122.15
Prev. close $109.23 52-week low $72.13
Day low $109.07 Volume 3,997,869
Day high $112.20 Avg. volume 5,788,134
50-day MA $105.22 Dividend yield 2.12%
200-day MA $101.02 Market Cap 150.34B

Medtronic plc. Ordinary Shares (MDT) Company Bio

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.

MDT Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$111.84$35.88 -67%

Below please find a table outlining a discounted cash flow forecast for MDT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Medtronic plc ranked in the 22th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:

  • MDT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 25.52% of tickers in our DCF set.
  • Medtronic plc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 8. This value is greater than merely 19.06% stocks in the Healthcare sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Medtronic plc? See BAX, GMED, OFIX, SRDX, and ABT.

MDT Latest News Stream

Event/Time News Detail
Loading, please wait...

MDT Latest Social Stream

Loading social stream, please wait...

View Full MDT Social Stream

Latest MDT News From Around the Web

Below are the latest news stories about Medtronic plc that investors may wish to consider to help them evaluate MDT as an investment opportunity.

Medtronic to acquire medical device company that treats end-stage renal disease

Medtronic announced its sixth small acquisition of the year.

Star Tribune | October 2, 2020

Neuroprosthetics Market 2020: In-Depth Research On Market Size, Share, Growth Rate And Trends, 2027 | Medtronic, Inc., Neuropace, Cochlear Limited, Abbott, etc.

The recent report published by Reports and Data comprises of an in-depth assessment of the Global Neuroprosthetics Market. It assesses the ever-changing market dynamics and overall development of the industry. The report is fabricated with thorough primary and secondary research

OpenPR | October 2, 2020

Digital Patient Monitoring Devices Market Size Will Accelerate Rapidly In The Near Future With Leading Key Vendors: Medtronic Plc, Omron Corporation, ResMed, AT&T, Inc, Welch Allyn, GE Healthcare, Zephyr Technology Corporation

Patient monitoring devices in this report refer to the sensors which are used in smart wearable devices. The patient monitoring devices market is driven by increasing demand for wearable for infants and continuously evolving sensor technology. With increasing personal care

OpenPR | October 2, 2020

Global Regenerative Medicine Market Growth Analysis, Key Manufacturers and Forecast Period 2020-2026| DePuy Synthes, Medtronic, ZimmerBiomet

Regenerative Medicine Market is expected to grow significantly over next few years and generate considerable market for Regenerative Medicine. Market Report Expert has recently published a research report titled, “Regenerative Medicine Market Outlook and Statistics, 2020-2026". The report has been prepared

OpenPR | October 2, 2020

DoJ opens ventilator antitrust probe focused on Medtronic - WSJ

The U.S. Department of Justice is investigating if acquisitions by Medtronic (MDT) limited competition in ventilator manufacturing, WSJ reports, which adds that the company has received a civil subpoena from the DoJ requesting more information.The probe reportedly is centered on two acquisitions: when Covidien PLC, a device maker that sold...

Seeking Alpha | October 1, 2020

Read More 'MDT' Stories Here

MDT Price Returns

1-mo 7.78%
3-mo 16.73%
6-mo 14.01%
1-year 8.79%
3-year 51.36%
5-year 69.33%
YTD 0.41%
2019 27.34%
2018 15.18%
2017 15.90%
2016 -5.44%
2015 8.62%

MDT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MDT Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1622 seconds.